SCHEMBL24074140

SCHEMBL24074140

Nc1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.56
▸ RAB9A P51151 7/20 0.56
▸ ALDH1A1 P00352 5/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ GAA P10253 1/20 0.56
▸ STAT3 P40763 3/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ FADS1 O60427 1/20 0.43
▸ KDR P35968 1/20 0.42
▸ DDX3X O00571 1/20 0.41
▸ PTGS1 P23219 2/20 0.41
▸ PTGES O14684 1/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ PKM P14618 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ P2RX1 P51575 1/20 0.40
▸ CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27135218 0.85 CYP1A2 (0.55) NPC1RAB9AALDH1A1STAT3MEN1
SCHEMBL19632762 0.85 STAT3 (0.61) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL27134429 0.84 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2GAAMEN1KMT2A
SCHEMBL24074429 0.84 RAB9A (0.52) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL24072396 0.84 STAT3 (0.44) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL27134430 0.84 RAB9A (0.54) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL27134428 0.84 NPC1 (0.62) NPC1RAB9AALDH1A1STAT3MEN1
SCHEMBL24072487 0.83 NPC1 (0.61) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL24072296 0.82 CHRNB2 (0.51) NPC1RAB9AALDH1A1GAAMEN1
SCHEMBL24072305 0.82 CCNE1 (0.49) NPC1RAB9AALDH1A1SMN1; SMN2STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 NPC1 3949/4885RAB9A 3280/4885ALDH1A1 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback